Aerpio Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Aerpio Pharmaceuticals patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2 Filling date: 6 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: Combinations of Tie-2 Activators and Prostaglandins and Uses Thereof Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: SMALL MOLECULE ACTIVATORS OF TIE-2 Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: HPTP-BETA INHIBITORS Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Methods of treating intraocular pressure with activators of Tie-2 Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Multispecific antibodies that target HPTP-.beta. (VE-PTP) and VEGF Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Application | Utility: ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: HPTP-Beta inhibitors Filling date: 6 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: METHODS OF TREATING HYPERTENSION WITH ACTIVATORS OF TIE-2 Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Methods for treating vascular leak syndrome and cancer Filling date: 6 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: METHODS FOR TREATING VASCULAR LEAK SYNDROME Filling date: 6 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta) Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: TREATMENT OF OCULAR DISEASE Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: METHODS FOR TREATING VASCULAR LEAK SYNDROME Filling date: 6 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Showing 1 to 26 of 26 patents.